CY1118521T1 - Συνθεση εμβολιου και μεθοδος χρησης αυτου - Google Patents

Συνθεση εμβολιου και μεθοδος χρησης αυτου

Info

Publication number
CY1118521T1
CY1118521T1 CY20161101172T CY161101172T CY1118521T1 CY 1118521 T1 CY1118521 T1 CY 1118521T1 CY 20161101172 T CY20161101172 T CY 20161101172T CY 161101172 T CY161101172 T CY 161101172T CY 1118521 T1 CY1118521 T1 CY 1118521T1
Authority
CY
Cyprus
Prior art keywords
vaccine composition
vaccine
immunization
compressed
concentrated
Prior art date
Application number
CY20161101172T
Other languages
English (en)
Inventor
Gilad Gallili
Norbert Frydman
Original Assignee
Abic Biological Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Biological Laboratories Ltd. filed Critical Abic Biological Laboratories Ltd.
Publication of CY1118521T1 publication Critical patent/CY1118521T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σε σταθερή συμπυκνωμένη, συμπιεσμένη ή μορφοποιημένη ως σκληρό δισκίο σύνθεση εμβολίου που περιλαμβάνει τουλάχιστον ένα αποξηρανθέν με κατάψυξη αντιγονικό συστατικό και βοηθητικό διάλυσης. Επίσης παρέχεται μέθοδος που διευκολύνει την ανοσοποίηση ενός υποκειμένου έναντι ασθένειας που περιλαμβάνει τα στάδια, αρχικώς, διάλυσης, της συμπυκνωμένης, συμπιεσμένης ή μορφοποιημένης ως σκληρό δισκίο σύνθεσης εμβολίου σε συσκευασία πακέτο με αραιωτικό για σχηματισμό διαλύματος εμβολίου και χορήγηση του προκύπτοντος διαλύματος εμβολίου σε αποτελεσματική ποσότητα για ανοσοποίηση.
CY20161101172T 1999-08-24 2016-11-15 Συνθεση εμβολιου και μεθοδος χρησης αυτου CY1118521T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15051499P 1999-08-24 1999-08-24
PCT/US2000/022929 WO2001013896A1 (en) 1999-08-24 2000-08-21 A vaccine composition and method of using the same

Publications (1)

Publication Number Publication Date
CY1118521T1 true CY1118521T1 (el) 2017-07-12

Family

ID=22534899

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20161101172T CY1118521T1 (el) 1999-08-24 2016-11-15 Συνθεση εμβολιου και μεθοδος χρησης αυτου

Country Status (21)

Country Link
US (1) US6541001B1 (el)
EP (1) EP1212045B1 (el)
JP (1) JP5209160B2 (el)
CN (1) CN100406004C (el)
AU (1) AU779403B2 (el)
BR (1) BRPI0014142B8 (el)
CA (1) CA2382652A1 (el)
CY (1) CY1118521T1 (el)
DK (1) DK1212045T3 (el)
ES (1) ES2605109T3 (el)
HK (1) HK1047696A1 (el)
HU (1) HUP0202537A3 (el)
IL (2) IL148247A0 (el)
LT (1) LT1212045T (el)
MX (1) MXPA02001891A (el)
PL (1) PL364983A1 (el)
PT (1) PT1212045T (el)
RU (1) RU2277905C2 (el)
TR (1) TR200200477T2 (el)
WO (1) WO2001013896A1 (el)
ZA (1) ZA200201816B (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US20070248569A1 (en) 2003-01-07 2007-10-25 Michal Eisenbach-Schwartz Eye-Drop Vaccine Containing Copolymer 1 for Therapeutic Immunization
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
MXPA05009079A (es) * 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
JP5183068B2 (ja) * 2003-12-22 2013-04-17 フィンレイ，ウォーレン，エイチ 大気噴出凍結乾燥法による粉末形成
US20050175630A1 (en) * 2003-12-23 2005-08-11 Eyal Raz Immunogenic compositions and methods of use thereof
JP2006143594A (ja) * 2004-11-16 2006-06-08 Shionogi & Co Ltd 注射錠
JP2009522288A (ja) * 2005-12-28 2009-06-11 アルザ コーポレイション 安定な治療剤形
JP5214464B2 (ja) 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
DE102006054260A1 (de) * 2006-02-28 2007-09-27 Lohmann Animal Health Gmbh & Co. Kg Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
JP4935761B2 (ja) * 2008-06-02 2012-05-23 株式会社微生物化学研究所 家禽大腸菌症ワクチン
JP5841527B2 (ja) 2009-05-26 2016-01-13 アドバンスド バイオニュートリション コーポレーション 生物学的に活性な微生物および／または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN102725393B (zh) 2010-01-28 2015-12-02 先进生物营养公司 包含生物活性材料的干燥玻璃质组合物
WO2012075379A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Liquid viral formulations
AU2011336410B2 (en) 2010-12-02 2015-01-22 Oncolytics Biotech Inc. Lyophilized viral formulations
HUE035774T2 (en) 2011-08-12 2018-05-28 Merial Inc Biological substances, in particular vaccines, preserved by vacuum
JP6229188B2 (ja) * 2012-03-23 2017-11-15 アドバンスド バイオニュートリション コープ． 生体材料のための安定化組成物
TWI745278B (zh) * 2014-10-10 2021-11-11 以色列商艾畢克生物實驗有限公司 發泡性降低之疫苗組合物
ES2870623T3 (es) 2014-12-22 2021-10-27 The Univ Of Georgia Research Foundation Inc Sistema para vacunación de aves
DK3328215T3 (da) 2015-07-29 2021-09-13 Advanced Bionutrition Corp Stabilt tørre probiotiske sammensætninger til særlige kostanvendelser

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB929377A (en) 1961-02-09 1963-06-19 Carl Peter Varnet Foot and mouth disease implantation preparations
US3317393A (en) 1964-06-08 1967-05-02 Robert M Chanock Immunization by selective infection of the intestinal tract with an encapsulated live virus
US3458621A (en) * 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3603030A (en) 1969-08-29 1971-09-07 Remco Ind Inc Jumping toy
FR2082760A5 (en) 1970-03-26 1971-12-10 France Etat Aerosol immunisation appts - for freeze-dried vaccines
DD106660A1 (el) 1972-04-10 1974-06-20
US3893280A (en) 1972-06-21 1975-07-08 Burns Biotec Lab Inc Transfer packaging for biologicals
DE2237783A1 (de) 1972-08-01 1974-02-14 Bayern Freistaat Impfstoffzubereitung zur oralen pocken-impfung
DD117250A1 (el) 1974-11-20 1976-01-05
BE853923A (fr) 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4251509A (en) 1980-01-31 1981-02-17 Wisconsin Alumni Research Foundation Dry particulate vaccine for oral administration
US4458630A (en) 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS63264518A (ja) * 1987-04-21 1988-11-01 Wakamoto Pharmaceut Co Ltd 発泡性錠剤の製法
IE61575B1 (en) 1987-05-04 1994-11-16 Merck & Co Inc A stable lyophilized live herpes virus vaccine
US5710014A (en) 1988-02-11 1998-01-20 The United States Of America As Represented By The Department Of Health And Human Services Cloned cDNA for human procathepsin l.
US5472710A (en) 1988-04-16 1995-12-05 Schwarz Pharma Ag Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture
IL89899A (en) 1988-05-16 1992-12-01 Reynolds Tobacco Co R Smoking article with improved means for delivering flavorants
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
WO1991004757A1 (en) 1989-10-02 1991-04-18 Cima Labs, Inc. Effervescent dosage form and method of administering same
ATE150976T1 (de) * 1989-10-02 1997-04-15 Univ Arkansas Impfstoff-konjugate zur behandlung von vogelkrankheiten
JP3078013B2 (ja) * 1989-10-02 2000-08-21 エンブレックス インコーポレイテッド ワクチン接合体の使用方法、ワクチン調整物および製造品
DD289201A5 (de) 1989-11-28 1991-04-25 Fi Fuer Lungenkrankheiten Und Tuberkulose,De Verfahren zur herstellung einer immunmodulierenden vakzine gegen viren
DD289200A5 (de) 1989-11-28 1991-04-25 Forsch Lungenkrankheiten Und T Verfahren zur herstellung einer kombinationsvakzine mit intensivierter wirkung
US5091188A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
US5178882A (en) 1990-06-22 1993-01-12 The Regents Of The University Of California Viral decoy vaccine
NZ242065A (en) 1991-03-26 1996-06-25 Csl Ltd Delayed release implant having a degradable or rupturable polymeric coating
US5206219A (en) 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
MX9303992A (es) * 1992-07-06 1995-01-31 Harvard College Mutantes de eliminacion como vacunas para el colera.
AU6172194A (en) 1993-02-08 1994-08-29 Paravax, Inc. Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens
ATE234855T1 (de) * 1993-09-20 2003-04-15 Anadis Ltd Verfahren zur herstellung von immunoglobulinen aus colostrum und deren verwendung in pharmazeutischen zusammensetzungen
US5595761A (en) 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5576014A (en) 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
IL120202A (en) 1996-03-07 2001-03-19 Akzo Nobel Nv Container with freeze-dried vaccine components
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
CN1216471A (zh) * 1996-04-22 1999-05-12 彼得·R·罗斯席尔德 稳定的抗乙型肝炎疫苗片
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
AU4133397A (en) * 1996-10-28 1998-05-22 Pfizer Inc. Oral vaccines for young animals with an enteric coating
US6150340A (en) * 1997-02-07 2000-11-21 Smithkline Beecham Corporation RNA-dependent amidotransferase from Staphylococcus aureus
JPH1121122A (ja) * 1997-07-03 1999-01-26 Akou Kaisui Kk 水溶解性に優れた塩錠剤
DE19741114C2 (de) 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische
CU22700A1 (es) 1997-09-29 2001-07-31 Ct Ingenieria Genetica Biotech Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
GB9801870D0 (en) 1998-01-28 1998-03-25 Raby Limited Vaccine composition
US6562002B1 (en) * 1999-02-16 2003-05-13 Prismedical Corporation Single dose delivery device

Also Published As

Publication number Publication date
CN1379663A (zh) 2002-11-13
BRPI0014142B8 (pt) 2021-05-25
JP2003507414A (ja) 2003-02-25
TR200200477T2 (tr) 2002-06-21
LT1212045T (lt) 2016-12-12
CN100406004C (zh) 2008-07-30
HK1047696A1 (zh) 2003-03-07
PT1212045T (pt) 2016-11-22
BRPI0014142B1 (pt) 2016-09-27
IL148247A (en) 2014-01-30
WO2001013896A1 (en) 2001-03-01
IL148247A0 (en) 2002-09-12
ZA200201816B (en) 2003-05-28
ES2605109T3 (es) 2017-03-13
AU6793400A (en) 2001-03-19
PL364983A1 (en) 2004-12-27
DK1212045T3 (en) 2016-11-28
JP5209160B2 (ja) 2013-06-12
RU2277905C2 (ru) 2006-06-20
AU779403B2 (en) 2005-01-20
EP1212045B1 (en) 2016-08-17
BR0014142A (pt) 2002-07-02
HUP0202537A3 (en) 2004-05-28
MXPA02001891A (es) 2003-07-21
EP1212045A4 (en) 2008-02-20
HUP0202537A2 (hu) 2002-11-28
EP1212045A1 (en) 2002-06-12
CA2382652A1 (en) 2001-03-01
US6541001B1 (en) 2003-04-01

Similar Documents

Publication Publication Date Title
CY1118521T1 (el) Συνθεση εμβολιου και μεθοδος χρησης αυτου
CY1120574T1 (el) Παρασκευασμα ανοσοσφαιρινης και μεθοδος παρασκευης αυτου
NO20015073L (no) Vaksiner
ES2157447T3 (es) Composicion de vacuna que comprende un antigeno de polisacarido conjugado adsorbido en fosfato de aluminio.
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
NO20023829L (no) Proteosom influensavaksine
DK1326636T3 (da) Vaccinesammensætning
HUP0401606A2 (hu) West Nile vakcina
DK1404363T3 (da) Adjuvanssammensætning til mucosalt og injektionsfremførte vacciner
CY1111636T1 (el) Εμβολιο που περιεχει gp120 και nef kai/´h tat για ανοσοποιηση εναντι hiv
CY1108147T1 (el) Εμβολιο κατα των σεξουαλικως μεταδιδομενων νοσων
CY1112879T1 (el) Συνθεση εμβολιου
UY28398A1 (es) Método y parche de inmunización por disposición de microproyección
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
DK1307227T3 (da) Farmaceutiske sammensætninger
DE60144240D1 (de) Zusammensetzung mit immunogenen mikroteilchen
ATE458496T1 (de) Hiv-vakzine und anwendungsverfahren
YU24004A (sh) Interleukin-12 kao adjuvant veterinarske vakcine
DE60143363D1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
PT1024824E (pt) Composicao de vacina dispersivel solida para administracao oral
BR0111834A (pt) Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
AR117191A1 (es) Composiciones inmunogénicas
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
EA200300535A1 (ru) Способ получения антигенных структур, усиливающих специфическую перекрестную реактивность
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas